Dermatology Laboratory Training

Dermatology Laboratory Training

In this laboratory training, participants will be exposed to detailed procedures required to uphold exceptional compounding quality in the niche area of dermatology. With the implementation of innovative technologies and techniques, compounders will leave this course with the tools and knowledge needed to further their compounding practice.


No account yet? Register here to access.

ACTIVITY DESCRIPTION

Compounding offers customised solutions for the treatment of various dermatological conditions such as psoriasis, rosacea, acne, warts, and dermatitis, as well as for cosmetic applications such as skin lightening, peels, and anti-aging. Compounded preparations also play an integral role during the healing process of wounds and scars. Not only can customised wound care speed up the healing process and minimize the appearance of old scars, individual formulations can also be compounded specifically to reduce scar formation early in the healing process.

FEATURED FORMULAS

  • Ascorbic Acid 2%, Caffeine 1%, Epigallocatechin Gallate 1%, Methylsulfonylmethane 5% Topical Gel
  • Clindamycin 2%, Hydrocortisone 1%, Salicylic Acid 3% Topical Cream
  • Fluticasone Propionate 1%, Itraconazole 2% Topical Ointment
Note: Formulas are subject to change.

DURATION: 4 HOURS

COMPLETION REQUIREMENTS

"Attend in full, complete learning assessments, and complete the activity evaluation."

DECLARATIONS AND DISCLOSURES

This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.

FINANCIAL SUPPORT

This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.

COPYRIGHT

Activity material is Copyright© 2017-2023 LP3 Network Inc.